AstraZeneca, J&J resume Covid-19 vaccine trial in US


Team Udayavani, Oct 24, 2020, 11:56 AM IST

Washington: AstraZeneca and Johnson & Johnson have resumed COVID-19 vaccine trial in the United States, after briefly pausing the trials over “unexplained illness” in few volunteers.

Both the companies on Friday said that the “unexplained illness” in few volunteers appeared not to be related to the vaccine shot.

The final stage of testing of the COVID-19 vaccine candidate was paused in the US, as officials examine whether an illness in its trial poses a safety risk. That trial was stopped when a woman developed severe neurological symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, AstraZeneca said. However, the vaccine’s testing has resumed in other countries.

After a six-week pause, Federal health regulators gave AstraZeneca the go-ahead to resume the trials in US, concluding there was no evidence that the experimental vaccine had directly caused the neurological side effects reported in two participants.

Johnson & Johnson said that its trial, which had been on pause for 11 days, would restart after learning that a “serious medical event” in one study volunteer had “no clear cause.”

A Food and Drug Administration spokesperson declined to comment on the trial restarts.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Carbon capture and storage: where should the world store CO₂? It’s a moral dilemma

‘Transform yourself or … ‘: PM Modi’s warning to MPs at BJP parliamentary party meeting

In major change, UAE workweek to be Monday through Friday

End of an era: Germany’s Merkel bows out after 16 years

Madras High Court orders winding up of SpiceJet over outstanding dues

Karnataka is taking measures to set up more genomic sequencing labs: CM

Armed forces’ perseverance, courage are outstanding: PM Modi


Related Articles More

Karnataka govt forms 19-member committee to monitor Covid situation

COVID-19: New variant intensity lower if both jabs taken, says Sudhakar

COVID: Bangalore Airport announces enhanced measures for passengers from at-risk countries

COVID-19: 301 new cases, 7 deaths in Karnataka

Kerala posts 3,277 new COVID-19 cases, 168 deaths

MUST WATCH

The centuries-old British road bund : public protest

Coscinium fenestratum

NEWS BULLETIN 06-12-2021

Food Business Success Stories | Bahubali Home Products

Dog Theft in Shivamogga


Latest Additions

Carbon capture and storage: where should the world store CO₂? It’s a moral dilemma

PM Modi inaugurates major fertiliser plant, AIIMS in UP’s Gorakhpur

‘Transform yourself or … ‘: PM Modi’s warning to MPs at BJP parliamentary party meeting

In major change, UAE workweek to be Monday through Friday

Govt responsible for deadlock in RS: Kharge

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.